Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-05-27

Clinical Trial Update: Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes. [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy of alogliptin in combination with pioglitazone in patients with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actos (Pioglitazone)
  • Nesina (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-05-27